Front ; CONTENTS; STRUCTURE-FUNCTION STUDIES OF THE VOLTAGE-DEPENDENT CALCIUM CHANNELS; REGULATION OF CALCIUM CHANNELS BY PROTEIN PHOSPHORYLATION; INTERACTIONS OF LACIDIPINE AND OTHER CALCIUM CHANNEL DRUGS WITH BIOLOGICAL MEMBRANES: A STRUCTURAL MODEL FOR RECEPTOR/DRUG BINDING UTILIZING THE MEMBRANE BILAYER; REGULATION OF CALCIUM CHANNELS IN VASCULAR SMOOTH MUSCLE; CALCIUM AND THE PRODUCTION OF ENDOTHELIUM-DERIVED VASOACTIVE FACTORS; INSIGHTS IN TIlE CARDIOPROTECTIVE MECHANISM OF THE NEW DRUG R56865; DO THE DIFFERENCES BETWEEN CALCIUM ANTAGONISTS MATTER WHEN TREATING HYPERTENSION? EFFECTS OF LACIDIPINE ON ISCHEMIC AND REPERFUSED MYOCARDIUMCALCIUM ANTAGONISTS AND LIPID-LOWERING AGENTS IN THE PROTECTION OF THE ARTERIAL WALL; RECEPTOR-MEDIATED INHIBITION OF CALCIUM CURRENTS AND SYNAPTIC TRANSMISSION IN CULTURED HIPPOCAMPAL PYRAMIDAL NEURONS; CALCIUM ANTAGONIST AND SUBARACHNOID HEMORRHAGE; A NEW CLASS OF CALCIUM ANTAGONIST SELECTIVE FOR THE GI TRACT; INDEX.